CHEK2 GERMLINE VARIANTS AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT OUTCOMES

• Atte K Lahtinen,
• Jessica Koski,
• Jarmo Ritari,
• Kati Hyvärinen,
• Satu Koskela,
• Jukka Partanen,
• Kim Vettenranta,
• Minna Koskenvuo,
• Riitta Niittyvuopio,
• Urpu Salmenniemi,
• Maija Itälä-Remes,
• Kirsi Jahnukainen,
• Outi Kilpivaara,
• Ulla Wartiovaara- Kautto,
• Maarja Karu

Affiliations

Atte K Lahtinen

Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Medical and Clinical Genetics, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland

Jessica Koski

Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland

Jarmo Ritari

Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland

Kati Hyvärinen

Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland

Satu Koskela

Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland

Jukka Partanen

Research and Development, Finnish Red Cross Blood Service, Helsinki, Finland

Kim Vettenranta

New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Minna Koskenvuo

New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Riitta Niittyvuopio

Helsinki University Hospital, Comprehensive Cancer Center, Department of Hematology, and University of Helsinki, Helsinki, Finland

Urpu Salmenniemi

Helsinki University Hospital, Comprehensive Cancer Center, Department of Hematology, and University of Helsinki, Helsinki, Finland

Maija Itälä-Remes

Turku University Hospital, Department of Clinical Hematology and Stem Cell Transplant Unit, and University of Turku, Turku, Finland

Kirsi Jahnukainen

New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Outi Kilpivaara

Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland

Ulla Wartiovaara- Kautto

Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Helsinki University Hospital, Comprehensive Cancer Center, Department of Hematology, and University of Helsinki, Helsinki, Finland. ulla.wartiovaara

Maarja Karu

New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Department of Hematology and Oncology, Tallinn Children's Hospital, Tallinn, Estonia